LICENSE AGREEMENT BY AND BETWEEN GLAXOSMITHKLINE AND VIROPHARMA INCORPORATEDLicense Agreement • November 12th, 2003 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
This LICENSE AGREEMENT (the “Agreement”) is made this 8th day of August, 2003 (the “Effective Date”), by and among SmithKline Beecham Corporation, a company organized and existing under the laws of the Commonwealth of Pennsylvania, and having its principal place of business at One Franklin Plaza, Philadelphia, Pennsylvania 19102 (“SB”), Glaxo Group Limited, a company incorporated under the laws of England and having its principal place of business at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 ONN, UK (“GGL”), (SB and GGL are collectively referred herein to as “GSK”) and ViroPharma Incorporated, a company organized and existing under the laws of the State of Delaware, and having its principal place of business at 405 Eagleview Boulevard, Exton, PA 19341 (“ViroPharma”). For purposes of this Agreement, GSK and ViroPharma shall also include each company’s respective Affiliates.
